BOLD
Price
$1.21
Change
+$0.03 (+2.54%)
Updated
Jul 18 closing price
Capitalization
27.09M
28 days until earnings call
IPSC
Price
$0.58
Change
-$0.00 (-0.00%)
Updated
Jul 18 closing price
Capitalization
50.04M
18 days until earnings call
Interact to see
Advertisement

BOLD vs IPSC

Header iconBOLD vs IPSC Comparison
Open Charts BOLD vs IPSCBanner chart's image
Boundless Bio
Price$1.21
Change+$0.03 (+2.54%)
Volume$58.87K
Capitalization27.09M
Century Therapeutics
Price$0.58
Change-$0.00 (-0.00%)
Volume$639.69K
Capitalization50.04M
BOLD vs IPSC Comparison Chart in %
Loading...
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLD vs. IPSC commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLD is a Hold and IPSC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (BOLD: $1.21 vs. IPSC: $0.58)
Brand notoriety: BOLD and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLD: 28% vs. IPSC: 66%
Market capitalization -- BOLD: $27.09M vs. IPSC: $50.04M
BOLD [@Biotechnology] is valued at $27.09M. IPSC’s [@Biotechnology] market capitalization is $50.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, BOLD is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 4 TA indicator(s) are bullish while IPSC’s TA Score has 6 bullish TA indicator(s).

  • BOLD’s TA Score: 4 bullish, 4 bearish.
  • IPSC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than BOLD.

Price Growth

BOLD (@Biotechnology) experienced а +1.68% price change this week, while IPSC (@Biotechnology) price change was -3.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

BOLD is expected to report earnings on Aug 18, 2025.

IPSC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPSC($50M) has a higher market cap than BOLD($27.1M). IPSC YTD gains are higher at: -42.495 vs. BOLD (-58.276). IPSC has higher annual earnings (EBITDA): -5.99M vs. BOLD (-72.59M). IPSC has more cash in the bank: 165M vs. BOLD (138M). BOLD has less debt than IPSC: BOLD (48.6M) vs IPSC (52.7M). IPSC has higher revenues than BOLD: IPSC (115M) vs BOLD (0).
BOLDIPSCBOLD / IPSC
Capitalization27.1M50M54%
EBITDA-72.59M-5.99M1,211%
Gain YTD-58.276-42.495137%
P/E Ratio0.16N/A-
Revenue0115M-
Total Cash138M165M84%
Total Debt48.6M52.7M92%
TECHNICAL ANALYSIS
Technical Analysis
BOLDIPSC
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRV265.974.16
+1.59%
Travelers Companies (The)
ALKS29.22-0.14
-0.48%
Alkermes plc
INLX13.90-0.10
-0.71%
Intellinetics
ELDN3.70-0.08
-2.12%
Eledon Pharmaceuticals
SBGI14.71-0.35
-2.29%
Sinclair

BOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with KMSTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then KMSTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
+2.54%
KMSTF - BOLD
56%
Loosely correlated
N/A
DSGN - BOLD
38%
Loosely correlated
-1.00%
CCCC - BOLD
37%
Loosely correlated
+6.42%
OCUL - BOLD
37%
Loosely correlated
-0.44%
IPSC - BOLD
37%
Loosely correlated
+0.10%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
+0.10%
CRSP - IPSC
58%
Loosely correlated
+18.22%
CRBU - IPSC
55%
Loosely correlated
+12.02%
KYTX - IPSC
52%
Loosely correlated
-4.18%
RXRX - IPSC
52%
Loosely correlated
+5.80%
NTLA - IPSC
51%
Loosely correlated
+1.94%
More